Abstract Details

<< Back to Detailed Agenda

9/23/2018  |   1:15 PM - 2:15 PM   |  Diamond Ballroom I

CMV 101: What is Congenital CMV? Why is it Important? How Can it be Prevented?

This session is designed to be an overview of Congenital CMV. The presenter will cover basic information about transmission, prevention, prevalence, treatment, and intervention.

  • Identify two updates on reducing impact of congenital CMV
  • Describe Maternal CMV infection during pregnancy
  • List two efforts being made to increase awareness of cCMV


No handouts have been uploaded.

Gail Demmler-Harrison (Primary Presenter), gdemmler@bcm.edu;
Professor of Pediatrics at Baylor College of Medicine with over 30 years experience in the research and clinical management of infants with congenital CMV infection; PI of the HOuston Longitudinal Congenital CMV Followup Study; co author or author of numerous publicaitons, chapters and presenter at national and international meetings


Financial - Receives Honoraria excluding diversified mutual funds,Speaker,Other financial benefit for Other activities from Merck & Co .   Receives Grants for Other activities from Microgen Labs.  

Nonfinancial - No relevant nonfinancial relationship exists.


Financial - Receives support from Merck & Company Microgen Laboratories.